𝛼SK or Search

ENTITY

Eisai Co Ltd (4523 JP)

241

Analysis

Health Care • Japan

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

more

Refresh

Exchange Announcement • 02 Oct 2026 14:30

Notification Regarding Receipt Of Dividend From A Consolidated Subsidiary

Exchange Announcement • 16 Sep 2026 14:00

Leqembi Pen (Subcutaneous Formulation Of Leqembi) Approved In Japan

Exchange Announcement • 03 Sep 2026 12:00

Leqembi (Lecanemab) Subcutaneous Formulation As An Initiation Treatment For Early Alzheimer’S Disease Approved In China

Exchange Announcement • 03 Aug 2026 14:30

Consolidated Financial Report [Ifrs] For The Three-Month Period Ended June 30, 2026

Exchange Announcement • 03 Aug 2026 14:30

Fy2026 (Ending March 31,2027) First Quarter Financial Results　Reference Data

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4

x